Iterative Health
Diane Shay is an experienced quality management professional with a strong background in the pharmaceutical and medical device industries. Currently serving as the Vice President of Quality at Iterative Health since January 2022, Diane has previously held similar leadership roles at EyePoint Pharmaceuticals and scPharmaceuticals Inc. Diane's extensive experience includes positions such as Sr. Director Quality at scPharmaceuticals Inc., Quality and Regulatory Head at SpringLeaf Therapeutics, and Director of Post Market Surveillance at Haemonetics. Diane's career began with roles in corporate quality and quality engineering at various organizations, including Accellent Inc. and Millipore. Diane holds a Bachelor's degree in Medical Technology from Massachusetts College of Liberal Arts and a Master's degree in Quality Systems Management from The National Graduate School of Quality Management.
This person is not in any teams
This person is not in any offices
Iterative Health
1 followers
Iterative Health is pioneering the use of artificial intelligence-based precision medicine in gastroenterology (GI), with the aim of helping to optimize clinical trials investigating treatment of inflammatory bowel disease (IBD). We use advanced machine learning and computer vision to interpret endoscopic images along with other types of data, helping clinicians to better assess patients with potential GI problems. This gives practitioners enhanced capabilities in the detection, annotation, disease scoring and treatment of GI related diseases. Iterative Health is initially applying these advances towards standardizing disease severity characterization for inflammatory bowel disease. Ultimately, the company aims to establish more meaningful endpoints to serve as better predictors of both therapeutic response and disease outcomes. The company is headquartered in Cambridge, Massachusetts.
Employees
51-200